|
5KK2
Architecture of fully occupied GluA2 AMPA receptor - TARP complex elucidated by single particle cryo-electron microscopy
Deposited 2016-06-20
|
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 8
PDB declaration: octameric
|
Chain E
1–323(323 aa)
Chain F
1–323(323 aa)
Chain G
1–323(323 aa)
Chain H
1–323(323 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 7.30 Å
|
|
5VOT
Structure of AMPA receptor-TARP complex
Deposited 2017-05-03
|
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 8
PDB declaration: octameric
|
Chain E
1–323(323 aa)
Chain F
1–323(323 aa)
Chain G
1–323(323 aa)
Chain H
1–323(323 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 4.90 Å
|
|
5VOU
Structure of AMPA receptor-TARP complex
Deposited 2017-05-03
|
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 8
PDB declaration: octameric
|
Chain E
1–323(323 aa)
Chain F
1–323(323 aa)
Chain G
1–323(323 aa)
Chain H
1–323(323 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 6.40 Å
|
|
5VOV
Structure of AMPA receptor-TARP complex
Deposited 2017-05-03
|
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 8
PDB declaration: octameric
|
Chain E
1–323(323 aa)
Chain F
1–323(323 aa)
Chain G
1–323(323 aa)
Chain H
1–323(323 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 7.70 Å
|
|
6NJL
Architecture and subunit arrangement of native AMPA receptors
Deposited 2019-01-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 14
PDB declaration: tetradecameric
|
Chain F
1–323(323 aa)
Chain H
1–323(323 aa)
|
Not recorded
|
ZK1 {[7-morpholin-4-yl-2,3-dioxo-6-(trifluoromethyl)-3,4-dihydroquinoxalin-1(2H)-yl]methyl}phosphonic acid × 4
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 6.70 Å
|
|
6NJM
Architecture and subunit arrangement of native AMPA receptors
Deposited 2019-01-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 16
PDB declaration: hexadecameric
|
Chain F
1–323(323 aa)
Chain H
1–323(323 aa)
|
Not recorded
|
ZK1 {[7-morpholin-4-yl-2,3-dioxo-6-(trifluoromethyl)-3,4-dihydroquinoxalin-1(2H)-yl]methyl}phosphonic acid × 4
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 4
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 6.50 Å
|
|
6NJN
Architecture and subunit arrangement of native AMPA receptors
Deposited 2019-01-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 15
PDB declaration: pentadecameric
|
Chain F
1–323(323 aa)
Chain H
1–323(323 aa)
|
Not recorded
|
ZK1 {[7-morpholin-4-yl-2,3-dioxo-6-(trifluoromethyl)-3,4-dihydroquinoxalin-1(2H)-yl]methyl}phosphonic acid × 4
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 6.50 Å
|
|
8C1R
Resting state homomeric GluA2 F231A mutant AMPA receptor in complex with TARP gamma-2
Deposited 2022-12-21
|
Different construct
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 8
PDB declaration: octameric
|
Chain E
2–323(322 aa)
Chain F
2–323(322 aa)
Chain G
2–323(322 aa)
Chain H
2–323(322 aa)
|
Not recorded
|
ZK1 {[7-morpholin-4-yl-2,3-dioxo-6-(trifluoromethyl)-3,4-dihydroquinoxalin-1(2H)-yl]methyl}phosphonic acid × 4
PLM PALMITIC ACID × 7
OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 4
POV (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate × 5
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.20 Å
|
|
8C1S
Transmembrane domain of resting state homomeric GluA2 F231A mutant AMPA receptor in complex with TARP gamma 2
Deposited 2022-12-21
|
Different construct
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 8
PDB declaration: octameric
|
Chain E
2–323(322 aa)
Chain F
2–323(322 aa)
Chain G
2–323(322 aa)
Chain H
2–323(322 aa)
|
Not recorded
|
PLM PALMITIC ACID × 6
OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 4
POV (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate × 4
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.00 Å
|
|
8P3Q
Homomeric GluA2 flip R/G-unedited Q/R-edited F231A mutant in tandem with TARP gamma-2, desensitized conformation 3
Deposited 2023-05-18
|
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 8
PDB declaration: octameric
|
Chain E
1–323(323 aa)
Chain F
1–323(323 aa)
Chain G
1–323(323 aa)
Chain H
1–323(323 aa)
|
Not recorded
|
PLM PALMITIC ACID × 7
OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 4
POV (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate × 5
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.95 Å
|
|
8P3S
Homomeric GluA2 flip R/G-unedited Q/R-edited F231A mutant in tandem with TARP gamma-2, desensitized conformation 2
Deposited 2023-05-18
|
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 8
PDB declaration: octameric
|
Chain E
1–323(323 aa)
Chain F
1–323(323 aa)
Chain G
1–323(323 aa)
Chain H
1–323(323 aa)
|
Not recorded
|
PLM PALMITIC ACID × 7
OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 4
POV (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate × 5
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.95 Å
|
|
8P3X
Homomeric GluA2 flip R/G-edited Q/R-edited F231A mutant in tandem with TARP gamma-2, desensitized conformation 1
Deposited 2023-05-18
|
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 8
PDB declaration: octameric
|
Chain E
1–323(323 aa)
Chain F
1–323(323 aa)
Chain G
1–323(323 aa)
Chain H
1–323(323 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.36 Å
|
|
8P3Y
Homomeric GluA2 flip R/G-edited Q/R-edited F231A mutant in tandem with TARP gamma-2, desensitized conformation 3
Deposited 2023-05-18
|
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 8
PDB declaration: octameric
|
Chain E
1–323(323 aa)
Chain F
1–323(323 aa)
Chain G
1–323(323 aa)
Chain H
1–323(323 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.55 Å
|
|
8P3Z
Homomeric GluA2 flip R/G-edited Q/R-edited F231A mutant in tandem with TARP gamma-2, desensitized conformation 2
Deposited 2023-05-18
|
Different ligand/ion
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 8
PDB declaration: octameric
|
Chain E
1–323(323 aa)
Chain F
1–323(323 aa)
Chain G
1–323(323 aa)
Chain H
1–323(323 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.46 Å
|
|
9E9D
Structure of full length AMPA receptor GluA2 and auxiliary subunit TARP gamma-2 in complex with anti-miR 17 oligonucleotide RGLS4326
Deposited 2024-11-08
|
Different construct
Different oligomeric state
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Insufficient information
Homooligomer;Protein × 4
PDB declaration: tetrameric
|
Chain A
2–208(207 aa)
Chain B
2–208(207 aa)
Chain C
2–208(207 aa)
Chain D
2–208(207 aa)
|
Not recorded
|
A1BX3 O-{[(1S,3S,4R,6S,7R)-7-{[(R)-{[(1R,3R,4R,6S,7R)-3-(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)-7-hydroxy-6-methyl-2,5-dioxabicyclo[2.2.1]heptan-1-yl]methoxy}(sulfanyl)phosphoryl]oxy}-3-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-6-methyl-2,5-dioxabicyclo[2.2.1]heptan-1-yl]methyl} O-[(2R,3S,4R,5S)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-methoxy-2-methyloxolan-3-yl] hydrogen (R)-phosphorothioate × 4
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.24 Å
|
|
9E9E
Structure of AMPA receptor GluA2 and auxiliary subunit TARP gamma-2 (LBD-TMD) in complex with anti-miR 17 oligonucleotide RGLS4326
Deposited 2024-11-08
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Insufficient information
Homooligomer;Protein × 4
PDB declaration: tetrameric
|
Chain A
2–208(207 aa)
Chain B
2–208(207 aa)
Chain C
2–208(207 aa)
Chain D
2–208(207 aa)
|
Mutation:N48D
Mutation:N48D
Mutation:N48D
Mutation:N48D
|
A1BX3 O-{[(1S,3S,4R,6S,7R)-7-{[(R)-{[(1R,3R,4R,6S,7R)-3-(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)-7-hydroxy-6-methyl-2,5-dioxabicyclo[2.2.1]heptan-1-yl]methoxy}(sulfanyl)phosphoryl]oxy}-3-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-6-methyl-2,5-dioxabicyclo[2.2.1]heptan-1-yl]methyl} O-[(2R,3S,4R,5S)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-methoxy-2-methyloxolan-3-yl] hydrogen (R)-phosphorothioate × 4
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.24 Å
|
|
9HPC
The TMD and the LBD region of the AMPAR complex GluA3- TARP gamma2 in the apo state.
Deposited 2024-12-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Insufficient information
Homooligomer;Protein × 8
PDB declaration: octameric
|
Chain A
2–323(322 aa)
Chain B
2–323(322 aa)
Chain C
2–323(322 aa)
Chain D
2–323(322 aa)
Chain W
2–323(322 aa)
Chain X
2–323(322 aa)
Chain Y
2–323(322 aa)
Chain Z
2–323(322 aa)
|
Mutation:R439G
Mutation:R439G
Mutation:R439G
Mutation:R439G
Mutation:R439G
Mutation:R439G
Mutation:R439G
Mutation:R439G
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.59 Å
|
|
9HPE
The NTD dimer and the interfacing LBD region of the AMPAR complex GluA3- TARP gamma2 in the apo state
Deposited 2024-12-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Insufficient information
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain B
2–323(322 aa)
Chain C
2–323(322 aa)
|
Mutation:R439G
Mutation:R439G
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 4
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.90 Å
|
|
9HPF
The NTD dimer and the interfacing LBD region of the AMPAR complex GluA3- TARP gamma2 in the desensitised state.
Deposited 2024-12-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Insufficient information
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
2–323(322 aa)
Chain B
2–323(322 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.77 Å
|
|
9HPG
The NTD dimer and the interfacing LBD region of the AMPAR complex GluA3(R439G,R163I)- TARP gamma2 in the apo state.
Deposited 2024-12-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Insufficient information
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain B
2–323(322 aa)
Chain C
2–323(322 aa)
|
Mutation:R439G,R163I
Mutation:R439G,R163I
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.35 Å
|
|
9HPK
Open state TMD-LBD of the GluA3(R439G) with TARP gamma2
Deposited 2024-12-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Insufficient information
Homooligomer;Protein × 8
PDB declaration: octameric
|
Chain A
2–323(322 aa)
Chain B
2–323(322 aa)
Chain C
2–323(322 aa)
Chain D
2–323(322 aa)
Chain W
2–323(322 aa)
Chain X
2–323(322 aa)
Chain Y
2–323(322 aa)
Chain Z
2–323(322 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.59 Å
|
|
9NR7
The structure of GluA1/A4 LBD-TMD in Noelin-AMPAR complex
Deposited 2025-03-14
|
Different construct
Different mutation/modification
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 8
PDB declaration: octameric
|
Chain F
5–208(204 aa)
Chain H
5–208(204 aa)
|
Not recorded
|
ZK1 {[7-morpholin-4-yl-2,3-dioxo-6-(trifluoromethyl)-3,4-dihydroquinoxalin-1(2H)-yl]methyl}phosphonic acid × 4
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 4.18 Å
|
|
9NR9
The structure of GluA1/A4 LBD-TMD with 2 TARPs
Deposited 2025-03-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain F
5–208(204 aa)
Chain H
5–208(204 aa)
|
Not recorded
|
ZK1 {[7-morpholin-4-yl-2,3-dioxo-6-(trifluoromethyl)-3,4-dihydroquinoxalin-1(2H)-yl]methyl}phosphonic acid × 4
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 4.22 Å
|
|
9NRA
The structure of GluA1/A4 LBD-TMD with 4 auxiliary subunits
Deposited 2025-03-14
|
Different construct
Different mutation/modification
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 8
PDB declaration: octameric
|
Chain F
5–208(204 aa)
Chain H
5–208(204 aa)
|
Not recorded
|
ZK1 {[7-morpholin-4-yl-2,3-dioxo-6-(trifluoromethyl)-3,4-dihydroquinoxalin-1(2H)-yl]methyl}phosphonic acid × 4
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 4.18 Å
|
|
9QDN
GluA4 in complex with TARP-2, resting state I, structure of TMD/LBD
Deposited 2025-03-06
|
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 8
PDB declaration: octameric
|
Chain E
1–323(323 aa)
Chain F
1–323(323 aa)
Chain G
1–323(323 aa)
Chain H
1–323(323 aa)
|
Not recorded
|
PLM PALMITIC ACID × 16
OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 4
E2Q 6-nitro-2,3-bis(oxidanylidene)-1,4-dihydrobenzo[f]quinoxaline-7-sulfonamide × 4
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.71 Å
|
|
9QFH
The composite map of of the AMPAR complex GluA3- TARP gamma2 in the apo state.
Deposited 2025-03-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Insufficient information
Homooligomer;Protein × 8
PDB declaration: octameric
|
Chain A
2–323(322 aa)
Chain B
2–323(322 aa)
Chain C
2–323(322 aa)
Chain D
2–323(322 aa)
Chain W
2–323(322 aa)
Chain X
2–323(322 aa)
Chain Y
2–323(322 aa)
Chain Z
2–323(322 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.90 Å
|
|
9RMS
GluA4 in complex with TARP-2, Resting II state, structure of TMD/LBD domains
Deposited 2025-06-18
|
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 8
PDB declaration: octameric
|
Chain E
1–323(323 aa)
Chain F
1–323(323 aa)
Chain G
1–323(323 aa)
Chain H
1–323(323 aa)
|
Not recorded
|
E2Q 6-nitro-2,3-bis(oxidanylidene)-1,4-dihydrobenzo[f]quinoxaline-7-sulfonamide × 4
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.80 Å
|
|
9RMW
GluA4 in complex with TARP-2, open state, structure of TMD/LBD domains
Deposited 2025-06-18
|
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 8
PDB declaration: octameric
|
Chain E
1–323(323 aa)
Chain F
1–323(323 aa)
Chain G
1–323(323 aa)
Chain H
1–323(323 aa)
|
Not recorded
|
PLM PALMITIC ACID × 18
OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 2
CYZ CYCLOTHIAZIDE × 4
GLU GLUTAMIC ACID × 4
CA CALCIUM ION × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.90 Å
|
|
9RN4
GluA4 in complex with TARP-2, desensitized state, structure of TMD/LBD domains
Deposited 2025-06-19
|
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 8
PDB declaration: octameric
|
Chain E
1–323(323 aa)
Chain F
1–323(323 aa)
Chain G
1–323(323 aa)
Chain H
1–323(323 aa)
|
Not recorded
|
PLM PALMITIC ACID × 4
CA CALCIUM ION × 1
OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 4
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.40 Å
|
|
9RN7
GluA4 in complex with TARP-2, Desensitized state, structure of TMD domain
Deposited 2025-06-19
|
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 8
PDB declaration: octameric
|
Chain E
1–323(323 aa)
Chain F
1–323(323 aa)
Chain G
1–323(323 aa)
Chain H
1–323(323 aa)
|
Not recorded
|
PLM PALMITIC ACID × 4
CA CALCIUM ION × 1
OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 4
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.10 Å
|
|
9RNH
GluA4 in complex with TARP-2, Resting II state, structure of TMD domain
Deposited 2025-06-19
|
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 8
PDB declaration: octameric
|
Chain E
1–323(323 aa)
Chain F
1–323(323 aa)
Chain G
1–323(323 aa)
Chain H
1–323(323 aa)
|
Not recorded
|
PLM PALMITIC ACID × 2
OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 4
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.10 Å
|